Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion type Assertion NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_head.
- NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion description "[The prevalence of serum anti-MCV in patients with early RA (78.2%, 133/170) was significantly higher than that of other rheumatologic patients and patients with infectious diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_provenance.
- NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion evidence source_evidence_literature NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_provenance.
- NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion SIO_000772 19447936 NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_provenance.
- NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion wasDerivedFrom befree-20140225 NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_provenance.
- NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_assertion wasGeneratedBy ECO_0000203 NP808369.RAFHjgps0c_kkcEgVU-Qldc_wQO2JLTj_hRLUu5he_Ego130_provenance.